Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530061 · ClinicalTrials.gov registry record · NA
The Satiating Effect of Eggs in Children
A NA study of Appetite, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01530061: Completed NA study of Appetite, sponsored by Pennington Biomedical Research Center.
NCT01530061 is a NA study of Appetite that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 28 participants, below the 41-participant average among 6 other Appetite trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01530061, a NA study of Appetite, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine which breakfast (egg breakfast or bagel breakfast) has the most beneficial effect on appetite.
Primary Outcome
Measure calories consumed at lunch time.
Conditions Studied
Interventions
- OTHER Egg Breakfast
- OTHER Bagel Breakfast
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01530061 record still lists
NCT01530061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 41-participant average among 6 other Appetite trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Appetite appearing as the primary indexed condition, and to 2 interventions - of which Egg Breakfast is the first listed.
NCT01530061 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01530061 about?
NCT01530061 is a clinical study titled "The Satiating Effect of Eggs in Children". This study will determine which breakfast (egg breakfast or bagel breakfast) has the most beneficial effect on appetite.
What is the current status of trial NCT01530061?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-02. Estimated completion is 2013-11.
What conditions does trial NCT01530061 study?
This clinical trial studies the following conditions: Appetite.
What interventions are being tested in trial NCT01530061?
The interventions under investigation include: Egg Breakfast (OTHER), Bagel Breakfast (OTHER).
Who is sponsoring clinical trial NCT01530061?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01530061 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appetite
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages
RECRUITING · NA
-
The Acute Effect of Vaping on Food Intake
COMPLETED · NA
-
Pasta Formulations, Portion Sizes and Their Effect on Appetite
COMPLETED · NA
-
Dietary Pork, Appetite and Weight Loss in Human
COMPLETED · NA
-
Effects of Energy and Physical Density Manipulation on Appetite
COMPLETED · NA
-
Brain Regulation of Appetite in Twins
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia